Myxoid Round Cell Liposarcoma Drug Market, Global Outlook and Forecast 2022-2028

February 2022 | 62 pages | ID: MC64249696BFEN
Market Monitor Global

Abstracts

Myxoid/round Cell Liposarcoma is also known as myxoliposarcoma is a malignant tumor that occurs in the body’s fat tissue most preferable found in the limbs. It is characterized by unusual pattern of metastasis to extrapulmonary sites. It has been found to be in geriatric male population.

This report contains market size and forecasts of Myxoid Round Cell Liposarcoma Drug in Global, including the following market information:

Global Myxoid Round Cell Liposarcoma Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Myxoid Round Cell Liposarcoma Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

By Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Myxoid Round Cell Liposarcoma Drug include Johnson & Johnson, Adaptimmune, GlaxoSmithKline plc, Merck & Co., Inc, Novartis, Infinity Pharmaceuticals, Inc, Mirati Therapeutics,Inc, Eli Lilly and Recordati SpA. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Myxoid Round Cell Liposarcoma Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Myxoid Round Cell Liposarcoma Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Myxoid Round Cell Liposarcoma Drug Market Segment Percentages, by Type, 2021 (%)

• By Drug
• Trabectedin
• Mechlorethamine
• Others
• By Therapy
• Chemotherapy
• Radiation Therapy
• Others
• By Routes of Administration
• Injectable
• Oral

Global Myxoid Round Cell Liposarcoma Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Myxoid Round Cell Liposarcoma Drug Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Myxoid Round Cell Liposarcoma Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Myxoid Round Cell Liposarcoma Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Myxoid Round Cell Liposarcoma Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Myxoid Round Cell Liposarcoma Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• Adaptimmune
• GlaxoSmithKline plc
• Merck & Co., Inc
• Novartis
• Infinity Pharmaceuticals, Inc
• Mirati Therapeutics,Inc
• Eli Lilly
• Recordati SpA

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Myxoid Round Cell Liposarcoma Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Myxoid Round Cell Liposarcoma Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MYXOID ROUND CELL LIPOSARCOMA DRUG OVERALL MARKET SIZE

2.1 Global Myxoid Round Cell Liposarcoma Drug Market Size: 2021 VS 2028
2.2 Global Myxoid Round Cell Liposarcoma Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Myxoid Round Cell Liposarcoma Drug Players in Global Market
3.2 Top Global Myxoid Round Cell Liposarcoma Drug Companies Ranked by Revenue
3.3 Global Myxoid Round Cell Liposarcoma Drug Revenue by Companies
3.4 Top 3 and Top 5 Myxoid Round Cell Liposarcoma Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Myxoid Round Cell Liposarcoma Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Myxoid Round Cell Liposarcoma Drug Players in Global Market
  3.6.1 List of Global Tier 1 Myxoid Round Cell Liposarcoma Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Myxoid Round Cell Liposarcoma Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Myxoid Round Cell Liposarcoma Drug Market Size Markets, 2021 & 2028
  4.1.2 Trabectedin
  4.1.3 Mechlorethamine
  4.1.4 Others
4.2 By Type - Global Myxoid Round Cell Liposarcoma Drug Revenue & Forecasts
  4.2.1 By Type - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2017-2022
  4.2.2 By Type - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2023-2028
  4.2.3 By Type - Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Myxoid Round Cell Liposarcoma Drug Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Homecare
  5.1.4 Specialty Clinics
  5.1.5 Others
5.2 By Application - Global Myxoid Round Cell Liposarcoma Drug Revenue & Forecasts
  5.2.1 By Application - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2017-2022
  5.2.2 By Application - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2023-2028
  5.2.3 By Application - Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Myxoid Round Cell Liposarcoma Drug Market Size, 2021 & 2028
6.2 By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue & Forecasts
  6.2.1 By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2017-2022
  6.2.2 By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue, 2023-2028
  6.2.3 By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Myxoid Round Cell Liposarcoma Drug Revenue, 2017-2028
  6.3.2 US Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.3.3 Canada Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.3.4 Mexico Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Myxoid Round Cell Liposarcoma Drug Revenue, 2017-2028
  6.4.2 Germany Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.4.3 France Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.4.4 U.K. Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.4.5 Italy Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.4.6 Russia Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.4.8 Benelux Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Myxoid Round Cell Liposarcoma Drug Revenue, 2017-2028
  6.5.2 China Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.5.3 Japan Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.5.4 South Korea Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.5.6 India Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Myxoid Round Cell Liposarcoma Drug Revenue, 2017-2028
  6.6.2 Brazil Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.6.3 Argentina Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Myxoid Round Cell Liposarcoma Drug Revenue, 2017-2028
  6.7.2 Turkey Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.7.3 Israel Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028
  6.7.5 UAE Myxoid Round Cell Liposarcoma Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.1.4 Johnson & Johnson Myxoid Round Cell Liposarcoma Drug Revenue in Global Market (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 Adaptimmune
  7.2.1 Adaptimmune Corporate Summary
  7.2.2 Adaptimmune Business Overview
  7.2.3 Adaptimmune Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.2.4 Adaptimmune Myxoid Round Cell Liposarcoma Drug Revenue in Global Market (2017-2022)
  7.2.5 Adaptimmune Key News
7.3 GlaxoSmithKline plc
  7.3.1 GlaxoSmithKline plc Corporate Summary
  7.3.2 GlaxoSmithKline plc Business Overview
  7.3.3 GlaxoSmithKline plc Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.3.4 GlaxoSmithKline plc Myxoid Round Cell Liposarcoma Drug Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline plc Key News
7.4 Merck & Co., Inc
  7.4.1 Merck & Co., Inc Corporate Summary
  7.4.2 Merck & Co., Inc Business Overview
  7.4.3 Merck & Co., Inc Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.4.4 Merck & Co., Inc Myxoid Round Cell Liposarcoma Drug Revenue in Global Market (2017-2022)
  7.4.5 Merck & Co., Inc Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.5.4 Novartis Myxoid Round Cell Liposarcoma Drug Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Infinity Pharmaceuticals, Inc
  7.6.1 Infinity Pharmaceuticals, Inc Corporate Summary
  7.6.2 Infinity Pharmaceuticals, Inc Business Overview
  7.6.3 Infinity Pharmaceuticals, Inc Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.6.4 Infinity Pharmaceuticals, Inc Myxoid Round Cell Liposarcoma Drug Revenue in Global Market (2017-2022)
  7.6.5 Infinity Pharmaceuticals, Inc Key News
7.7 Mirati Therapeutics,Inc
  7.7.1 Mirati Therapeutics,Inc Corporate Summary
  7.7.2 Mirati Therapeutics,Inc Business Overview
  7.7.3 Mirati Therapeutics,Inc Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.7.4 Mirati Therapeutics,Inc Myxoid Round Cell Liposarcoma Drug Revenue in Global Market (2017-2022)
  7.7.5 Mirati Therapeutics,Inc Key News
7.8 Eli Lilly
  7.8.1 Eli Lilly Corporate Summary
  7.8.2 Eli Lilly Business Overview
  7.8.3 Eli Lilly Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.8.4 Eli Lilly Myxoid Round Cell Liposarcoma Drug Revenue in Global Market (2017-2022)
  7.8.5 Eli Lilly Key News
7.9 Recordati SpA
  7.9.1 Recordati SpA Corporate Summary
  7.9.2 Recordati SpA Business Overview
  7.9.3 Recordati SpA Myxoid Round Cell Liposarcoma Drug Major Product Offerings
  7.9.4 Recordati SpA Myxoid Round Cell Liposarcoma Drug Revenue in Global Market (2017-2022)
  7.9.5 Recordati SpA Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Myxoid Round Cell Liposarcoma Drug Market Opportunities & Trends in Global Market
Table 2. Myxoid Round Cell Liposarcoma Drug Market Drivers in Global Market
Table 3. Myxoid Round Cell Liposarcoma Drug Market Restraints in Global Market
Table 4. Key Players of Myxoid Round Cell Liposarcoma Drug in Global Market
Table 5. Top Myxoid Round Cell Liposarcoma Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Myxoid Round Cell Liposarcoma Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Myxoid Round Cell Liposarcoma Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Myxoid Round Cell Liposarcoma Drug Product Type
Table 9. List of Global Tier 1 Myxoid Round Cell Liposarcoma Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Myxoid Round Cell Liposarcoma Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Myxoid Round Cell Liposarcoma Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Myxoid Round Cell Liposarcoma Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Myxoid Round Cell Liposarcoma Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Myxoid Round Cell Liposarcoma Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Myxoid Round Cell Liposarcoma Drug Product Offerings
Table 32. Johnson & Johnson Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), (2017-2022)
Table 33. Adaptimmune Corporate Summary
Table 34. Adaptimmune Myxoid Round Cell Liposarcoma Drug Product Offerings
Table 35. Adaptimmune Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline plc Corporate Summary
Table 37. GlaxoSmithKline plc Myxoid Round Cell Liposarcoma Drug Product Offerings
Table 38. GlaxoSmithKline plc Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co., Inc Corporate Summary
Table 40. Merck & Co., Inc Myxoid Round Cell Liposarcoma Drug Product Offerings
Table 41. Merck & Co., Inc Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Myxoid Round Cell Liposarcoma Drug Product Offerings
Table 44. Novartis Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), (2017-2022)
Table 45. Infinity Pharmaceuticals, Inc Corporate Summary
Table 46. Infinity Pharmaceuticals, Inc Myxoid Round Cell Liposarcoma Drug Product Offerings
Table 47. Infinity Pharmaceuticals, Inc Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), (2017-2022)
Table 48. Mirati Therapeutics,Inc Corporate Summary
Table 49. Mirati Therapeutics,Inc Myxoid Round Cell Liposarcoma Drug Product Offerings
Table 50. Mirati Therapeutics,Inc Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly Corporate Summary
Table 52. Eli Lilly Myxoid Round Cell Liposarcoma Drug Product Offerings
Table 53. Eli Lilly Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), (2017-2022)
Table 54. Recordati SpA Corporate Summary
Table 55. Recordati SpA Myxoid Round Cell Liposarcoma Drug Product Offerings
Table 56. Recordati SpA Myxoid Round Cell Liposarcoma Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Myxoid Round Cell Liposarcoma Drug Segment by Type in 2021
Figure 2. Myxoid Round Cell Liposarcoma Drug Segment by Application in 2021
Figure 3. Global Myxoid Round Cell Liposarcoma Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Myxoid Round Cell Liposarcoma Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Myxoid Round Cell Liposarcoma Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Myxoid Round Cell Liposarcoma Drug Revenue in 2021
Figure 8. By Type - Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028
Figure 12. US Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028
Figure 16. Germany Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028
Figure 24. China Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Myxoid Round Cell Liposarcoma Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Myxoid Round Cell Liposarcoma Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Myxoid Round Cell Liposarcoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Adaptimmune Myxoid Round Cell Liposarcoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline plc Myxoid Round Cell Liposarcoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co., Inc Myxoid Round Cell Liposarcoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Myxoid Round Cell Liposarcoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Infinity Pharmaceuticals, Inc Myxoid Round Cell Liposarcoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mirati Therapeutics,Inc Myxoid Round Cell Liposarcoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly Myxoid Round Cell Liposarcoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Recordati SpA Myxoid Round Cell Liposarcoma Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)